Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr257 Inhibitors

Olr257 inhibitors represent a class of chemical compounds that target and inhibit the activity of the Olfactory Receptor 257 (Olr257), a member of the large family of G-protein-coupled receptors (GPCRs) found predominantly in the olfactory epithelium. These receptors are involved in the detection of odorants, and their inhibition can modulate olfactory signal transduction. Olr257, like other olfactory receptors, is a seven-transmembrane domain protein that binds to specific odorant molecules, leading to the activation of intracellular signaling pathways. The inhibition of Olr257 can occur through various mechanisms, such as competitive binding at the odorant-binding site or allosteric modulation, which alters the receptor's conformation and reduces its ability to interact with its natural ligands.

The development and study of Olr257 inhibitors involve the identification of small molecules that can selectively bind to Olr257 with high affinity and specificity. Structure-activity relationship (SAR) studies play a crucial role in optimizing these inhibitors by modifying their chemical structures to enhance binding interactions and improve selectivity. Advanced techniques such as molecular docking, computational modeling, and high-throughput screening are often employed to identify potential Olr257 inhibitors. Once identified, these compounds undergo further investigation to elucidate their binding mechanisms and interactions with Olr257 at the molecular level. Understanding these interactions is essential for the design of more potent inhibitors and for exploring the broader implications of Olr257 inhibition in the context of olfactory biology and the modulation of olfactory receptor signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Angiotensin II receptor antagonist, may affect cardiovascular regulation, impacting Olr257.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

Vitamin B3 derivative, can modulate NAD+ metabolism, potentially impacting Olr257.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Proton pump inhibitor, might alter gastric acid secretion, impacting Olr257.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Thiazolidinedione, could influence insulin sensitivity, potentially impacting Olr257.

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

Antiarrhythmic, may affect cardiac ion channels, impacting Olr257.

Raloxifene

84449-90-1sc-476458
1 g
$802.00
3
(0)

SERM, can modulate estrogen receptor activity, potentially impacting Olr257.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

Statin, might influence cholesterol synthesis, impacting Olr257.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blocker, may modulate cardiac and smooth muscle function, impacting Olr257.

Warfarin

81-81-2sc-205888
sc-205888A
1 g
10 g
$73.00
$246.00
7
(1)

Anticoagulant, can affect blood clotting pathways, potentially impacting Olr257.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 receptor antagonist, could influence sympathetic nervous system activity, impacting Olr257.